AI Maverick Intel Inc. Stock Analysis BINP
Bionoid Pharma, Inc. operates as a medical device company. The company is headquartered in Huntington Beach, California. The company went IPO on 2007-06-25. The Company’s principal asset is its AI Maverick Intel platform, which is designed to automate and enhance customer acquisition processes using machine learning, behavioral data analysis, and performance-driven optimization. The technology enables intelligent, two-way communication and data-driven engagement across healthcare, biotech, and other sectors. The company is also focused on Software-as-a-Service (SaaS) licensing, enterprise integration, and consulting services based on its AI technology stack.
Read More AI Maverick Intel Inc (BINP) Chart
Key Statistics of AI Maverick Intel Inc (BINP)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.05Volume
1200.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1.85MAvg. Volume
51.20KDividend Yield
-Financial Metrics & Statements of AI Maverick Intel Inc (BINP)
FAQ's for AI Maverick Intel Inc (BINP)
- According to Musaffa’s Shariah screening methodology, AI Maverick Intel Inc (BINP) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.